Lavaca Capital LLC Abb Vie Inc. Transaction History

Lavaca Capital LLC

$252 Million
Q4 2024

A detailed history of Lavaca Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lavaca Capital LLC holds 4,024 shares of ABBV stock, worth $785,082. This represents 0.28% of its overall portfolio holdings.

Number of Shares

4,024

Previous 3,738 7.65%

Holding current value

$785,082

Previous $738,000 3.12%

% of portfolio

0.28%

Previous 0.32%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$164.99 - $203.87 $47,187 - $58,306	286 Added 7.65%	4,024 $715,000
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $636,190 - $773,998	-3,883 Reduced 50.95%	3,738 $738,000
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $3,095 - $3,615	20 Added 0.26%	7,621 $1.31 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $223,108 - $254,211	1,396 Added 22.5%	7,601 $1.38 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $402,067 - $452,822	-2,922 Reduced 32.01%	6,205 $961,000
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $236,721 - $274,039	-1,772 Reduced 16.26%	9,127 $1.36 Million
Q2 2023 Aug 25, 2023	BUY	$132.51 - $164.9 $1.44 Million - $1.8 Million	10,899 New	10,899 $1.47 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $184,666 - $212,671	-1,277 Reduced 6.2%	19,336 $3.08 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $25,034 - $30,022	-181 Reduced 0.87%	20,613 $3.33 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $701,515 - $804,592	-5,227 Reduced 20.09%	20,794 $2.92 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $33,992 - $43,215	247 Added 0.96%	26,021 $3.89 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $4.17 Million - $5.18 Million	-31,609 Reduced 55.08%	25,774 $4.18 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $867,926 - $1.1 Million	-8,079 Reduced 12.34%	57,383 $7.77 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $1.11 Million - $1.25 Million	-10,387 Reduced 13.69%	65,462 $7.06 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $695,438 - $774,758	6,610 Added 9.55%	75,849 $8.54 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $745,767 - $820,999	7,290 Added 11.77%	69,239 $7.49 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $80,490 - $108,670	1,000 Added 1.64%	61,949 $6.64 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $592,435 - $695,323	6,896 Added 12.76%	60,949 $5.34 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $66,619 - $89,147	908 Added 1.71%	54,053 $5.31 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $10,384 - $15,744	161 Added 0.3%	53,145 $4.05 Million
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $225,468 - $271,077	3,580 Added 7.25%	52,984 $4.01 Million
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $1.33 Million - $1.7 Million	20,213 Added 69.24%	49,404 $3.59 Million
Q1 2019 Apr 11, 2019	BUY	$77.14 - $90.79 $333,167 - $392,122	4,319 Added 17.36%	29,191 $2.35 Million
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $1.94 Million - $2.39 Million	24,872 New	24,872 $2.29 Million

Others Institutions Holding ABBV

# of Institutions

4,173

Shares Held

1.29B

Call Options Held

17M

Put Options Held

14.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lavaca Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lavaca Capital LLC with notifications on news.

Account

Lavaca Capital LLC Abb Vie Inc. Transaction History